Table 2 Baseline characteristics according to hospital survivability of patients with sepsis.

Age (year), median (IQR), n = 252

65 (52–76.75)

65 (53–76)

65 (52–78)

0.810

Sex (male), no. (%)

162/252 (64.3)

93/151 (61.6)

69/101 (68.3)

0.275

Collection batch, no. (%)

n = 252

n = 151

n = 101

0.007

 Collection 1 (Jan)

80 (31.7)

58 (38.4)

22 (21.8)

 Collection 2 (April)

62 (24.6)

27 (17.9)

35 (34.7)

 Collection 3 (July)

54 (21.4)

32 (21.2)

22 (21.8)

 Collection 4 (Oct)

56 (22.2)

34 (22.5)

22 (21.8)

Admission type, no. (%)

n = 252

n = 151

n = 101

0.195

 Medical

236 (93.7)

138 (91.4)

98 (97.0)

 Elective surgical

2 (0.8)

2 (1.3)

0

 Unscheduled surgical

14 (5.6)

11 (7.3)

3 (3.0)

Admission source, no. (%)

n = 252

n = 151

n = 101

0.505

 Emergency department

138 (54.8)

87 (57.6)

51 (50.5)

 Operating room

4 (1.6)

3 (2.0)

1 (1.0)

 General wards

56 (22.2)

33 (21.9)

23 (22.8)

 Other ICUs or HDU

16 (6.3)

10 (6.6)

6 (5.9)

 Inter-hospital transfer

37 (14.7)

18 (11.9)

19 (18.8)

 Others

1 (0.4)

0

1 (1.0)

Comorbidities, no. (%)

n = 252

n = 151

n = 101

 Cardiovascular disease

78 (31.0)

41 (27.2)

37 (36.6)

0.111

 Chronic lung disease

30 (11.9)

18 (11.9)

12 (1.9)

0.992

 Chronic neurological disease

36 (14.3)

28 (18.5)

8 (7.9)

0.018

 Chronic kidney disease

23 (9.1)

14 (9.3)

9 (8.9)

0.922

 Peptic ulcer disease

9 (3.6)

5 (3.3)

4 (4.0)

> 0.999

 Chronic liver disease

27 (10.7)

14 (9.3)

13 (12.9)

0.365

 Diabetes mellitus

67 (26.6)

40 (26.5)

27 (26.7)

0.966

 HIV infection

0

0

0

–

 Connective tissue disease

3 (1.2)

2 (1.3)

1 (1.0)

> 0.999

 Immunosuppression

10 (4.0)

7 (4.6)

3 (3.0)

0.744

Haematological malignancies

5 (2.0)

3 (2.0)

2 (2.0)

> 0.999

 Solid malignant tumours

12 (4.8)

6 (4.0)

6 (5.9)

0.551